{"id":846651,"title":"Archived 46: Recommendations on the use of Pfizer-BioNTech Comirnaty (3 mcg) COVID-19 vaccine in children 6 months to 4 years of age [2022-10-21] - Canada.ca","sourceCode":"phac","sourceName":"Public Health Agency of Canada","language":"en","captureDate":"2026-01-28","captureTimestamp":"2026-01-28T15:24:17.821000+00:00","jobId":7,"originalUrl":"https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/recommendations-use-pfizer-biontech-comirnaty-3-mcg-covid-19-vaccine-children-6-months-4-years.html","snippet":"Archived 46: Recommendations on the use of Pfizer-BioNTech Comirnaty (3 mcg) COVID-19 vaccine in children 6 months to 4 years of age [2022-10-21] Download in PDF format (1.87 MB, 27 pages) Organization: Public Health Agency of Canada Cat.: HP5-144/1-2022E-PDF ISBN:…","rawSnapshotUrl":"/api/snapshots/raw/846651","browseUrl":"https://replay.healtharchive.ca/job-7/20260128152417/https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/recommendations-use-pfizer-biontech-comirnaty-3-mcg-covid-19-vaccine-children-6-months-4-years.html#ha_snapshot=846651","mimeType":"text/html","statusCode":200,"captureBackend":"playwright_warc","captureFidelity":"fallback"}